Invention Grant
- Patent Title: Materials and methods for treating Friedreich's Ataxia
-
Application No.: US16942276Application Date: 2020-07-29
-
Publication No.: US11459363B2Publication Date: 2022-10-04
- Inventor: Ronald Mark Payne
- Applicant: The Trustees of Indiana University
- Applicant Address: US IN Indianapolis
- Assignee: The Trustees of Indiana University
- Current Assignee: The Trustees of Indiana University
- Current Assignee Address: US IN Indianapolis
- Agency: Faegre Drinker Biddle & Reath LLP
- Main IPC: A61K38/17
- IPC: A61K38/17 ; C07K14/47 ; C07K19/00 ; A61P25/28 ; A61P9/02 ; A61K9/00 ; A61K38/00
Abstract:
A Transactivator of Transcription-frataxin (TAT-FXN) fusion polypeptide useful in treating subjects diagnosed with Friedreich's Ataxia, hypertrophic cardiomyopathy, or both are disclosed, as are related methods of treatment and pharmaceutical compositions.
Public/Granted literature
- US20210047378A1 MATERIALS AND METHODS FOR TREATING FRIEDRICH'S ATAXIA Public/Granted day:2021-02-18
Information query
IPC分类:
